Molecular targets for treatment of breast cancer

Woo Chan Park, Lee Su Kim, Tae Hyun Kim, Byeong Woo Park, Ho Yong Park, Byung Joo Song, Jae Bok Lee, Chang Wan Jeon, Un Jong Choi

Research output: Contribution to journalReview article

Abstract

Advances in molecular biology have made it possible to understand the tumor biology of breast cancer at the molecular level and have revealed molecular targets for the therapy of breast cancer. Nowadays, targeting agents are used as mono-therapy or as combined therapy with other anticancer drugs for the treatment of breast cancer. Much more efforts is also being made in the development of better therapeutic agents targeting molecules having an important role in tumor biology. In this article, promising molecules for targeted therapy are reviewed for their roles in the pathophysiology and the treatment of breast cancer. We also introduce and summarize new preclinical agents, developed or on developing, with preliminary results from clinical trials. Given the progress currently being made, targeted therapy could become a main strategy for the treatment of breast cancer in the near future.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalJournal of Breast Cancer
Volume12
Issue number4
DOIs
Publication statusPublished - 2009 Dec 1

Fingerprint

Breast Neoplasms
Therapeutics
Molecular Biology
Neoplasms
Clinical Trials
Pharmaceutical Preparations

Keywords

  • Breast neoplasms
  • Targeting agent
  • Therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Park, W. C., Kim, L. S., Kim, T. H., Park, B. W., Park, H. Y., Song, B. J., ... Choi, U. J. (2009). Molecular targets for treatment of breast cancer. Journal of Breast Cancer, 12(4), 229-234. https://doi.org/10.4048/jbc.2009.12.4.229

Molecular targets for treatment of breast cancer. / Park, Woo Chan; Kim, Lee Su; Kim, Tae Hyun; Park, Byeong Woo; Park, Ho Yong; Song, Byung Joo; Lee, Jae Bok; Jeon, Chang Wan; Choi, Un Jong.

In: Journal of Breast Cancer, Vol. 12, No. 4, 01.12.2009, p. 229-234.

Research output: Contribution to journalReview article

Park, WC, Kim, LS, Kim, TH, Park, BW, Park, HY, Song, BJ, Lee, JB, Jeon, CW & Choi, UJ 2009, 'Molecular targets for treatment of breast cancer', Journal of Breast Cancer, vol. 12, no. 4, pp. 229-234. https://doi.org/10.4048/jbc.2009.12.4.229
Park WC, Kim LS, Kim TH, Park BW, Park HY, Song BJ et al. Molecular targets for treatment of breast cancer. Journal of Breast Cancer. 2009 Dec 1;12(4):229-234. https://doi.org/10.4048/jbc.2009.12.4.229
Park, Woo Chan ; Kim, Lee Su ; Kim, Tae Hyun ; Park, Byeong Woo ; Park, Ho Yong ; Song, Byung Joo ; Lee, Jae Bok ; Jeon, Chang Wan ; Choi, Un Jong. / Molecular targets for treatment of breast cancer. In: Journal of Breast Cancer. 2009 ; Vol. 12, No. 4. pp. 229-234.
@article{339b7f5280b44ce3a24b2eaf768b1b37,
title = "Molecular targets for treatment of breast cancer",
abstract = "Advances in molecular biology have made it possible to understand the tumor biology of breast cancer at the molecular level and have revealed molecular targets for the therapy of breast cancer. Nowadays, targeting agents are used as mono-therapy or as combined therapy with other anticancer drugs for the treatment of breast cancer. Much more efforts is also being made in the development of better therapeutic agents targeting molecules having an important role in tumor biology. In this article, promising molecules for targeted therapy are reviewed for their roles in the pathophysiology and the treatment of breast cancer. We also introduce and summarize new preclinical agents, developed or on developing, with preliminary results from clinical trials. Given the progress currently being made, targeted therapy could become a main strategy for the treatment of breast cancer in the near future.",
keywords = "Breast neoplasms, Targeting agent, Therapy",
author = "Park, {Woo Chan} and Kim, {Lee Su} and Kim, {Tae Hyun} and Park, {Byeong Woo} and Park, {Ho Yong} and Song, {Byung Joo} and Lee, {Jae Bok} and Jeon, {Chang Wan} and Choi, {Un Jong}",
year = "2009",
month = "12",
day = "1",
doi = "10.4048/jbc.2009.12.4.229",
language = "English",
volume = "12",
pages = "229--234",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "4",

}

TY - JOUR

T1 - Molecular targets for treatment of breast cancer

AU - Park, Woo Chan

AU - Kim, Lee Su

AU - Kim, Tae Hyun

AU - Park, Byeong Woo

AU - Park, Ho Yong

AU - Song, Byung Joo

AU - Lee, Jae Bok

AU - Jeon, Chang Wan

AU - Choi, Un Jong

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Advances in molecular biology have made it possible to understand the tumor biology of breast cancer at the molecular level and have revealed molecular targets for the therapy of breast cancer. Nowadays, targeting agents are used as mono-therapy or as combined therapy with other anticancer drugs for the treatment of breast cancer. Much more efforts is also being made in the development of better therapeutic agents targeting molecules having an important role in tumor biology. In this article, promising molecules for targeted therapy are reviewed for their roles in the pathophysiology and the treatment of breast cancer. We also introduce and summarize new preclinical agents, developed or on developing, with preliminary results from clinical trials. Given the progress currently being made, targeted therapy could become a main strategy for the treatment of breast cancer in the near future.

AB - Advances in molecular biology have made it possible to understand the tumor biology of breast cancer at the molecular level and have revealed molecular targets for the therapy of breast cancer. Nowadays, targeting agents are used as mono-therapy or as combined therapy with other anticancer drugs for the treatment of breast cancer. Much more efforts is also being made in the development of better therapeutic agents targeting molecules having an important role in tumor biology. In this article, promising molecules for targeted therapy are reviewed for their roles in the pathophysiology and the treatment of breast cancer. We also introduce and summarize new preclinical agents, developed or on developing, with preliminary results from clinical trials. Given the progress currently being made, targeted therapy could become a main strategy for the treatment of breast cancer in the near future.

KW - Breast neoplasms

KW - Targeting agent

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=74849116372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849116372&partnerID=8YFLogxK

U2 - 10.4048/jbc.2009.12.4.229

DO - 10.4048/jbc.2009.12.4.229

M3 - Review article

VL - 12

SP - 229

EP - 234

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 4

ER -